Valens Semiconductor enters the back half of May with a remarkable chart — the stock has more than doubled over the past month — and a fresh analyst upgrade providing cover for bulls to stay in.
The standout this week is the analyst action. Needham's N. Quinn Bolton raised his price target on VLN from $3 to $4 this morning, while maintaining a Buy rating. That move comes directly after Tuesday's Q1 earnings release and pushes the mean Street target to roughly $4.33, implying about 60% upside from the current price of $2.70. Bolton has been the most consistent follower of this name — initiating coverage in April 2025 and adjusting his target in lockstep with earnings prints. The current $4 target is well within range of the stock's recent trajectory: VLN climbed 103% over the past month and is up nearly 12% on the week, despite giving back 5% on Tuesday's session.
Positioning in the lending market is relaxed, which is notable given the magnitude of the rally. Short interest is running at roughly 0.78% of the free float — well below the level where bearish crowding becomes a genuine conversation. The borrow pool is mostly available, with utilization having jumped to 73% recently from below 30% at the start of May; the 52-week peak was a brief 100% episode on April 30 that quickly resolved. Borrowing costs are a nominal 0.84% annualised. None of this points to a squeeze setup — the move has been driven by buyers, not by shorts being forced to cover. Options sentiment is mildly more cautious than usual: the put/call ratio is running at 0.15, modestly above its 20-day average of 0.12, but nowhere near a defensive extreme.
The bull case centres on a recovery in the Pro-AV market, growing adoption of Valens' HDBaseT solutions, and early traction in MIPI A-PHY for automotive and industrial applications. The company committed to FY25 guidance of $73.5 million in revenue despite tariff headwinds, and its EPS surprise factor score ranks in the 89th percentile — suggesting it has a track record of beating estimates when it gets to the line. Bears point to the persistent EBITDA losses: the adjusted EBITDA deficit is projected to worsen slightly, and with a negative earnings yield the stock is valued on hope rather than current cash generation. The price-to-book multiple has expanded sharply — rising nearly 1.9x over the past 30 days in line with the price move — and the analyst recommendation differential factor ranks in the 95th percentile, meaning relative to history the Street is about as constructive as it gets.
The institutional register has a few names worth watching. ARK Investment Management added 472,876 shares in Q1, lifting its stake to 1.16 million. Magma Venture Partners entered with just over one million shares in mid-March. Marshall Wace built its position by 645,000 shares through year-end. On the other side, the insider tape has been consistently one-directional: every transaction over the past 90 days has been a sale. The net insider selling across the period totals around $129,000 in value — small in dollar terms, but the absence of any buying from senior executives during a doubling of the stock price is worth registering.
The last two earnings prints offer limited directional signal. The May 2025 release produced a 1-day move of just -0.4%, and the February 2025 print delivered a 4.6% gain on the day before fading 5.9% by the close of the following week. The most recent event — today's earnings call — carries no price-reaction data yet, as settlement is pending.
What to watch: whether the post-earnings institutional flow data corroborates the constructive analyst tone, and whether ARK and other recent buyers add further at current levels or begin trimming into the strength.
See the live data behind this article on ORTEX.
Open VLN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
